A method of determining the sequence of incorporation of monosaccharides in the synthesis of the branched oligosaccharide chain of a structural compound The biosynthesis of Tay-Sachs ganglioside  by Maccioni, Hugo J.F. et al.
Volume 23, number 2 FEBS LETTERS June 1972 
A METHOD OF DETERMINING THE SEQUENCE OF INCORPORATION OF 
MONOSACCHARIDES IN THE SYNTHESIS OF THE BRANCHED 
OLIGOSACCHARIDE CHAIN OF A STRUCTURAL COMPOUND 
The Biosynthesis of Tay-Sachs Ganglioside 
Hugo J.F. MACCIONJ, August0 ARCE and Ranwel CAPUTTO 
Departamento de Q&mica Bioldgica. Facultad de Ciencias Quimicas, Universidad National de Cdrdoba, 
Ciudad Universitaria, Cdrdoba, Argentina 
Received 26 April 1972 
1. Introduction 
The determination of the sequence of addition of 
the component monosaccharides of a branched oli- 
gosaccharide constituent of a subcellular structure 
presents difficulties for which there are presently no 
unambiguous solutions. Evidence obtained by syn- 
thesis with particulate enzymes and exogenous sub- 
strates is not definitive since it is not certain that the 
conditions, and the enzymes participating in the syn- 
thesis with endogenous and exogenous acceptors, are 
the same. For the synthesis of gangliosides, the path- 
ways worked out from the labeling of endogenous 
acceptors [l] are in agreement with some syntheses 
carried out with exogenous acceptors [2], but are in 
conflict with the synthesis of one of the disialogangli- 
osides [3] . (For a full discussion see [l] ). Recently a 
possible pathway was worked out on the basis of the 
compounds found in the cells. However, as the 
authors [4] recognized, the apparent absence of a 
compound does not necessarily mean that it is not an 
intermediate. 
Information on pathways of synthesis obtained 
from the labeling of endogenous acceptors can be ob- 
tained from the following consideration: if a struc- 
tural compound, which is synthesized by stepwise 
addition of several groups, is labeled by incubating 
the particles with several abeled donor nucleotides, 
the ratio: 
Specific radioactivity of component L - 
Specific radioactivity of nucleotide donor of L 
136 
(in which L is the last component to enter into the 
compound) must be higher than, or at least equal to 
(if the pool of immediate acceptor-precursor(s) is nil) 
the comparable ratio for any other component of the 
same compound. However, whereas the evidence of- 
fered by this method can be strong, it was not con- 
clusive in the study of the synthesis of gangliosides 
because unlabeled donor nucleotides were found in 
the particles and it is possible that an undetermined 
amount of any of these nucleotides participated in 
the reactions [I] . This limitation has been overcome 
for the case of disialogangliosides because a minimum 
relative value between the incorporation ofilr-acetyl- 
neuraminic acid (NeuNAc) and galactose can be 
worked out by relating the results to the incorpora- 
tion of the same two components into hematoside 
[S] , This test cannot however be applied to the syn- 
thesis of Tay-Sachs ganglioside. 
An approach, applicable to the synthesis of Tay- 
Sachs ganglioside, is considered in this communica- 
tion. The use of this method is possible when pre- 
cursors and products can be isolated. Provided that 
two or more components of an endogenous acceptor- 
precursor are labeled, the ratios of labeling of those 
components in the acceptor and in the product will 
tend to become equal. In scheme 1, for instance, the 
Tay-Sachs ganglioside may be found with an incor- 
poration ratio of NeuNAc to hexose equal to that of 
the hematoside, if this was the precursor, or with the 
GalNAc/hexoses incorporation ratio equal to the 
aminoglycoripid if this was the precursor. Moreover, 
since the component that enters last but one (NeuNAc 
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Scheme 1 
Cer-Glc-Gal-NeuNAc 
7 
(hematoside) 
4 
NeuNAc 
I 
Cer-Glc + Cer-Glc-Gal Cer-Glc-Gal 
L ? \ 
Cer-Glc-Gal-GamAc GalNAc 
(aminoglycolipid) (Tay-Sachs 
ganglioside) 
Scheme 1: Possible pathways for the biosynthesis of Tay-Sachs 
ganglioside (Cer = ceramide). 
or GalNAc) into the Tay-Sachs ganglioside is the one 
that completes its immediate precursor (hematoside 
or aminoglycolipid), the “last but one”/hexose in- 
corporation ratio cannot be higher in the Tay-Sachs 
ganglioside than in its immediate precursor. 
2. Materials and methods 
For preparation or determination of the following 
compounds, see the indicated references: CMP-N- 
[3H] acetylneuraminic acid, Tay-Sachs ganghoside 
and radioactivity measurements [l] ; aminoglycolipid 
[6] ; hematoside [7,8] ; hexoses [9] ; bound acid [lo] ; 
free sialic acid [ 1 l] and N-acetylgalactosamine [121. 
For thin-layer chromatography on silica gel the follow- 
ing solvents were used: 1) chloroform-methanol-3.5 
N NH4 OH (60:35:8, by vol); II) chloroform-methanol- 
water (66:30:4, by vol); III) chloroforn-methanol- 
cont. NH40H (66:30:5, by vol). 
Endogenous glycolipids were labeled by incubation 
of subcellular particles (obtained in sucrose [I] ) from 
25 g of brains from IS-day-old rats. The system of in- 
cubation contained, in a final volume of 25 ml, 0.28 
pmole of CMP-N- [” H] acetylneuraminic acid 
(9.86 X 10” cpm/l.cmole), 0.24 pmole of UDP-[UL4C] - 
galactose (New England Nuclear, 3.84 X 108 cpm/pmole), 
0.11 @mole of UDP-N-acetyl [14Cr] galactosamine (New 
England Nuclear, 8.6 X lo7 cpm/gmole), 40 pmoles 
of MnClz ,40 pmoles of MgClz , and 700 pmoles of 
potassium phosphate buffer pH 6.8. After 15 min at 
37” the reaction was stopped by addition of 20 vol of 
chloroform-methanol (2: 1, v/v) [ 131. To the filtered 
lipid extract 2 pmoles of aminoglycolipid, 1 I*mole of 
Tay-Sachs ganglioside and 0.2 pmole of hematoside 
were added and then it was partitioned twice with 
water. The hematoside and Tay-Sachs ganglioside 
were isolated as follows: the upper phase was made 
0.25 M in KC1 and partitioned twice with theoretical 
lower phase [ 141 ; the lower phases were pooled and 
evaporated, the residue taken in water, dialyzed 
overnight against water and passed through a Sepha- 
dex G-25-40 column [3,15]. The effluent was 
evaporated, the residue was taken in a small volume 
of chloroform-methanol (2: 1, v/v) and passed 
through a DEAE-cellulose column (Sigma, fine) 
equilibrated with the same solvent mixture; the col- 
umn was thoroughly washed with this mixture and 
the gangliosides were eluted with chloroform- 
methanol-9 N NH40H (60:30:4.5, by vol). Hema- 
toside and Tay-Sachs ganglioside were separated and 
purified by thin-layer chromatography [8] using, 
successively, solvent II and I until constant specific 
radioactivities were reached. The aminoglycolipid 
was isolated from the lower phase by passing it 
through a DEAE-cellulose column using the sequence 
5 of Rouser et al. [ 161 . It was purified by thin-layer 
chromatography with, successively, solvents III and 
II. 
3. Results and discussion 
Table 1 shows that the NeuNAc/hexose incorpora- 
tion ratios were approximately equal in hematoside 
and in Tay-Sachs ganglioside, whereas the GalNAc/ 
hexose incorporation ratio was higher in Tay-Sachs 
ganglioside than in aminoglycolipid. These results 
support the hypothesis that the pathway for the syn- 
thesis of Tay-Sachs ganglioside is through the hema- 
toside rather than through aminoglycolipid. This dif- 
fers from the recently proposed pathway for this syn- 
thesis in a mouse neuroblastoma cell line [4]. 
The last column of table 1 shows that the GalNAc/ 
NeuNAc incorporation ratio obtained in Tay-Sachs 
ganglioside is higher than 1, thus showing that the two 
lines of evidence discussed in the introduction pro- 
duced coincident results. 
On the assumption that in the membranes from the 
subcellular particles there is only one pool of hema- 
toside that is the precursor of the pool of Tay-Sachs 
ganglioside, the results of table 1 would unambiguously 
I.37 
Volume 23, number 2 -/ FEBS LETTERS June 1972 
Table 1 
Molar incorporation ratios of monosaccharide components of 
the Tay-Sachs ganglioside and of its possible precursors. 
_____ 
NeuNAc GalNAc GalNAc 
hexose hexose NeuNAc 
Cer-Glc-Gal-NeuNAc 
(hematoside) 1.7 - - 
Cer-Glc-Gal-GalNAc 
(aminoglycolipid) _ 2.5 _ 
NeuNAc 
Cer-Glc-Gal’ 
\ 
GalNAc 
1.8 5.2 2.9 
(Tay-Sachs ganglioside) 
__~_. 
Hematoside, Tay-Sachs ganglioside and aminoglycolipid were 
purified as indicated under Materials and methods. The 
NeuNAc/hexose and NeuNAc/(hexose + GalNAc) radioactivity 
ratios in, respectively, the hematoside and the Tay-Sachs 
ganglioside were determined by counting 3H and 14C in the 
intact compounds. The GalNAc/hexose radioactivity ratios 
in aminoglycolipid and Tay-Sachs ganglioside were deter- 
mined as follows: each glycolipid was hydrolyzed for 7 hr at 
100” in 3 N HCI and the hydrolyzate was partitioned with 
chloroform. The upper phase was dried, dissolved in water 
and passed through, successively, Dowex 1 (formate) and 
Dower 50 (H+). The r4C radioactivity in. the effluent plus 
washing was ascribed to neutral hexoses. The 14C radioactivity 
eluted from the Dowex 50 with 2 N HCl was ascribed to galac- 
tosamine. The method was checked by determining the speci- 
fic radioactivities of both the mixture of glucose and galactose, 
and the galactosamine after they were subjected to thin-layer 
chromatography with propanol: water (7:3, by vol) [17]. The 
NeuNAc/hexose and GalNAc/NeuNAc radioactivity ratios in the 
Tay-Sachs ganglioside were calculated from the NeuNAc/(hexose 
+ GalNAc), and the GalNAc/hexose radioactivity ratios found 
for the same ganglioside. Molar ratios were calculated from 
the specific radioactivities of added nucleotides. 
solve the problem. However, evidence from in viva ex- 
periments [8] indicates that the main pool of hema- 
toside is not a precursor for the major gangliosides; the 
hematosides that are precursors (transient pool) of the 
different gangliosides apparently do not enter into a 
common pool but are kept attached to the place in 
which each ganglioside is synthesized. However, the 
striking similarity between the NeuNAc/hexose incor- 
poration ratios in the hematoside and the Tay-Sachs 
ganglioside, indicates that some kind of relationship 
exists between their synthesis in vitro. 
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